Transcranial magnetic stimulation as a tool for understanding neurophysiology in Huntington's disease: a review.

Philpott AL, Fitzgerald PB, Cummins TD, Georgiou-Karistianis N.

Neurosci Biobehav Rev. 2013 Sep;37(8):1420-33. doi: 10.1016/j.neubiorev.2013.05.009. Review.

Tracking brain palmitoylation change: predominance of glial change in a mouse model of Huntington's disease.

Wan J, Savas JN, Roth AF, Sanders SS, Singaraja RR, Hayden MR, Yates JR 3rd, Davis NG.

Chem Biol. 2013 Nov 21;20(11):1421-34. doi: 10.1016/j.chembiol.2013.09.018.

Motor, emotional and cognitive deficits in adult BACHD mice: a model for Huntington's disease.

Abada YS, Schreiber R, Ellenbroek B.

Behav Brain Res. 2013 Feb 1;238:243-51. doi: 10.1016/j.bbr.2012.10.039.

Short and long term outcome of bilateral pallidal stimulation in chorea-acanthocytosis.

Miquel M, Spampinato U, Latxague C, Aviles-Olmos I, Bader B, Bertram K, Bhatia K, Burbaud P, Burghaus L, Cho JW, Cuny E, Danek A, Foltynie T, Garcia Ruiz PJ, Giménez-Roldán S, Guehl D, Guridi J, Hariz

PLoS One. 2013 Nov 5;8(11):e79241. doi: 10.1371/journal.pone.0079241.

Expression of expanded CAG transcripts triggers nucleolar stress in Huntington's disease.

Tsoi H, Chan HY.

Cerebellum. 2013 Jun;12(3):310-2. doi: 10.1007/s12311-012-0447-6.

Gowers' Queen Square case notes on chorea: a 21st century re-appraisal.

Vale TC, Glass PG, Lees A, Cardoso F.

Eur Neurol. 2013;69(1):48-52. doi: 10.1159/000343628.

A randomized feasibility study of a 12-week community-based exercise program for people with Huntington's disease.

Busse M, Quinn L, Debono K, Jones K, Collett J, Playle R, Kelly M, Simpson S, Backx K, Wasley D, Dawes H, Rosser A; Members of the COMMET-HD Management Group..

J Neurol Phys Ther. 2013 Dec;37(4):149-58. doi: 10.1097/NPT.0000000000000016.

A novel human embryonic stem cell-derived Huntington's disease neuronal model exhibits mutant huntingtin (mHTT) aggregates and soluble mHTT-dependent neurodegeneration.

Lu B, Palacino J.

FASEB J. 2013 May;27(5):1820-9. doi: 10.1096/fj.12-219220.

Downregulation of cannabinoid receptor 1 from neuropeptide Y interneurons in the basal ganglia of patients with Huntington's disease and mouse models.

Horne EA, Coy J, Swinney K, Fung S, Cherry AE, Marrs WR, Naydenov AV, Lin YH, Sun X, Keene CD, Grouzmann E, Muchowski P, Bates GP, Mackie K, Stella N.

Eur J Neurosci. 2013 Feb;37(3):429-40. doi: 10.1111/ejn.12045.

Correlations between behavioural and oxidative parameters in a rat quinolinic acid model of Huntington's disease: protective effect of melatonin.

Antunes Wilhelm E, Ricardo Jesse C, Folharini Bortolatto C, Wayne Nogueira C.

Eur J Pharmacol. 2013 Feb 15;701(1-3):65-72. doi: 10.1016/j.ejphar.2013.01.007.

Managing juvenile Huntington's disease.

Quarrell OW, Nance MA, Nopoulos P, Paulsen JS, Smith JA, Squitieri F.

Neurodegener Dis Manag. 2013 Jun 1;3(3). doi: 10.2217/nmt.13.18.

JAK/STAT Signalling in Huntington's Disease Immune Cells.

Träger U, Magnusson A, Lahiri Swales N, Wild E, North J, Lowdell M, Björkqvist M.

PLoS Curr. 2013 Dec 13;5. pii: ecurrents.hd.5791c897b5c3bebeed93b1d1da0c0648. doi: 10.1371/currents.hd.5791c897b5c3bebeed93b1d1da0c0648.

Factors Affecting Aggregate Formation in Cell Models of Huntington's Disease and Amyotrophic Lateral Sclerosis.

Lazarev VF, Sverchinskyi DV, Ippolitova MV, Stepanova AV, Guzhova IV, Margulis BA.

Acta Naturae. 2013 Apr;5(2):81-9.

A novel method for detecting 7-methyl guanine reveals aberrant methylation levels in Huntington disease.

Thomas B, Matson S, Chopra V, Sun L, Sharma S, Hersch S, Rosas HD, Scherzer C, Ferrante R, Matson W.

Anal Biochem. 2013 May 15;436(2):112-20. doi: 10.1016/j.ab.2013.01.035.

Demonstration of choreic movements in a case of chorea gravidarum.

Pathania M, Lali BS, Yadav NK, Chaturvedi A.

BMJ Case Rep. 2013 Feb 15;2013. pii: bcr2012008234. doi: 10.1136/bcr-2012-008234. No abstract available.